Jump to content

Draft:Andrzej Mikołaj Pilc

From Wikipedia, the free encyclopedia


  • Comment: All major statements require sources to verify them. We also do not want essays or extended CVs on academics. Ldm1954 (talk) 12:08, 2 May 2025 (UTC)

Andrzej Mikołaj Pilc
Born(1948-04-20)20 April 1948
Łódź, Poland
CitizenshipPolish
Alma materMedical University of Łódź
Occupation(s)neurobiologist,
psychopharmacologist,
pharmacologist
Employer(s)Maj Institute of Pharmacology of the Polish Academy of Sciences, Jagiellonian University Medical College

Andrzej Mikołaj Pilc[1] (born 20 April 1948) is a Polish neuropharmacologist.[2] best known for his research on the psychopharmacology of anxiety and depression. Associated with the Maj Institute of Pharmacology of the Polish Academy of Sciences in Kraków, at which he is a professor.[3] Author of over 500 publications,[4] who has been devoted to research on metabotropic glutamate receptors for many years. His most important scientific achievements include participation in the discovery of up-regulation of GABA B receptors after antidepressants[5] and the antidepressant and anxiolytic effects of mGlu5 receptor antagonists.[6][7][8] In the years 1991-2019, head of the Department of Neurobiology at the Maj Institute of Pharmacology of the Polish Academy of Sciences in Kraków and in the years 1997-2019 head of the Department of Drug Management at the Collegium Medicum of the Jagiellonian University. Professor of medical sciences, corresponding member of the 5th Division of the Polish Academy of Sciences (PAN), active member of the Faculty of Medicine of the Polish Academy of Arts and Sciences (PAU).

Biography

[edit]

Early Life

[edit]

He was born in Łódź to Józef Pilc and Barbara (née Koźmińska). He was the great-grandson of Konstanty Walczak, a prominent manufacturer from Łódź,[9] who was one of the four factory owners of Polish origin in the city. His mother remarried, and his stepfather was an internal medicine specialist, Dr. Włodzimierz Honikman, under whose influence he decided to study medicine.

Scientific Development

[edit]

In 1972, he obtained the degree of Doctor of Medical Sciences.[10] In 1977, he earned his PhD at the Faculty of Medicine of the Medical University of Łódź, under the supervision of Professor Czesław Maśliński. In 1987, he was awarded a postdoctoral degree (habilitation) in medical sciences, specializing in medical biology, at the same faculty. In 1997, he received the title of Professor of Medical Sciences.[11]

Employment

[edit]

In 1972, he began working at the Department of Biogenic Amines of the Polish Academy of Sciences in Łódź, headed by Professor Czesław Maśliński. Between 1975 and 1976, he participated in a 12-month International Training Course in Modern Biology at the Biological Research Center in Szeged, Hungary. In 1979, he joined the Institute of Pharmacology of the Polish Academy of Sciences in Kraków, working in the Department of Biochemistry led by Professor Jerzy Vetulani. In 1982, he undertook a one-year postdoctoral internship at Synthelabo in Paris, where, under the supervision of Dr. Kenneth George Lloyd, he conducted research on GABA B receptors. From 1984 to 1985, he worked at the University of Texas Medical School at Houston (TX, USA) as part of the research team led by Professor Salvatore J. Enna. From 1991 to 2019, he served as the Head of the Department of Neurobiology at the Institute of Pharmacology of the Polish Academy of Sciences. Between 1992 and 1994, he was also employed as an Associate Professor in the Department of Pharmacology at the School of Medicine, Kuwait University. Since 1997, he has also been affiliated with the Faculty of Health Sciences at the Jagiellonian University Medical College, where he headed the Department of Drug Management from 1997 to 2019.

Scientific work

[edit]

While working at the Department of Biogenic Amines, his research focused on the effects of histamine in the brain. In collaboration with Professor Jerzy Nowak, he co-authored several scientific papers.[12][13] His later cooperation with Professor Jerzy Vetulani resulted in a series of influential publications.[14][15][16] These contributions led to Professor Jerzy Vetulani receiving the prestigious Anna-Monika Prize in 1983, part of which he used to personally compensate Dr. Pilc with an amount equivalent to four years’ salary at the time—during the communist era in Poland, the average monthly wage was approximately $20. During his postdoctoral fellowship at Synthelabo in Paris, he published work on the effects of antidepressants and electroconvulsive therapy on metabotropic γ-aminobutyric acid (GABA) receptors, particularly GABA B receptors, which are believed to play a role in the pathophysiology of depression[5].[17] While in Houston, he co-authored studies indicating the involvement of α2-adrenergic receptors in the mechanism of action of antidepressants[18][19] In the 1990s, he initiated research on metabotropic glutamate receptors (mGluRs),[20] contributing to the discovery of anxiolytic,[21] antidepressant and antiparkinsonian[22] effects of ligands targeting these receptors. More recently, his research has explored the enhancement of the antidepressant effects of hallucinogens through modulation of mGluR ligands.[23][24][25] He has been recognized among the top 2% of the most frequently cited scientists worldwide, ranking 891st out of 140,593 researchers in the field of pharmacology.[26][27][28]

Membership in scientific associations and organizations

[edit]

He has been actively involved in numerous scientific societies and committees. From 1995 to 2001, he served as the Chairman of the Kraków Branch of the Polish Pharmacological Society, and from 2007 to 2010, he was Vice-Chairman of the Society at the national level. Since 1994, he has been a member of the Polish Society for Research on the Nervous System (PTBUN). He is on the board of the Polish Society for Histamine Research

He was a member of the Neurobiology Committee of the Polish Academy of Sciences from 2003 to 2010, as well as a member of the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences until 2007. From 2015 to 2018, he served on the Science Committee of the Polish Academy of Sciences. Internationally, he has been a member of the Society for Neuroscience (SfN) in the United States since 1986, and of the European College of Neuropsychopharmacology (ECNP) since 2006. From 2014 to 2020, he chaired the Life Sciences Committee of the Committee for the Evaluation of Scientific Units (KEJN).

Awards

[edit]

He has received numerous prestigious awards throughout his career. In 2003, he was honored with the Tadeusz Browicz Award from the Faculty of Medical Sciences, PAU.[29] In 2008, he received the Jędrzej Śniadecki Award from the Faculty of Medical Sciences of the Polish Academy of Sciences,[30] followed by the Jędrzej Śniadecki Medal in 2019.[31] Additionally, he was awarded the Golden Cross of Merit in 2004.[32] Ranked as Poland's top medical scientist by Top Medicine Scientists in 2022.[33]

Hobbies

[edit]

Mountaineering

[edit]

He has a passion for mountaineering and has climbed in various mountain ranges around the world, including the Tatra Mountains, the Alps, the Iranian Mountains, the Rocky Mountains, the Alaskan Mountains, Australia, the Himalayas, and the Karakoram.[34][35]

Scientometrics

[edit]

He is also known for his work in scientometrics, notably as the creator of the first ranking of Polish scientists based on citation indexes.[36]

Selected publications

[edit]
  • Tatarczyńska, E., Kłodzińska, A., Chojnacka-Wójcik, E., Pałucha, A., Gasparini, F., Kuhn, R., Pilc, A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. British Journal of Pharmacology, 2001, 132 (7), pp. 1423-1430. Cited 303 times.[37]
  • Nowak, G., Siwek, M., Dudek, D., Zieba, A., Pilc, A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Polish Journal of Pharmacology, 2003, 55 (6), pp. 1143-1147. Cited 212 times.[38]
  • Palucha, A., Pilc, A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs Pharmacology and Therapeutics, 2007, 115 (1), pp. 116-147. Cited 202 times.[39]
  • Lloyd, K.G., Thuret, F., Pilc, A. Upregulation of γ-aminobutyric acid (GABA) B binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressants and electroshock. Journal of Pharmacology and Experimental Therapeutics, 1985, 235 (1), pp. 191-199. Cited 200 times.[40]
  • Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha, A., Szewczyk, B., Tatarczyńska, E., Chojnacka-Wójcik, E., Wierońska, J.M. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology, 2002, 43 (2), pp. 181-187. Cited 152 times.[41]
  • Pilc, A., Chaki, S., Nowak, G., Witkin, J.M. Mood disorders: Regulation by metabotropic glutamate receptors. Biochemical Pharmacology, 2008, 75 (5), pp. 997-1006. Cited 151 times.[42]
  • Palucha, A., Klak, K., Branski, P., Van Der Putten, H., Flor, P.J., Pilc, A. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology, 2007, 194 (4), pp. 555-562. Cited 137 times.[43]
  • Pałucha, A., Tatarczyńska, E., Brański, P., Szewczyk, B., Wierońska, J.M., Kłak, K., Chojnacka-Wójcik, E., Nowak, G., Pilc, A. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology, 2004, 46 (2), pp. 151-159. Cited 133 times.[44]
  • Pilc, A., Wierońska, J.M., Skolnick, P. Glutamate-based antidepressants: Preclinical psychopharmacology. Biological Psychiatry, 2013, 73 (12), pp. 1125-1132. Cited 106 times[45]
  • Vetulani, J., Lebrecht, U., Pilc, A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. European Journal of Pharmacology, 1981, 76 (1), pp. 81-85. Cited 100 times.[46]

References

[edit]
  1. ^ "Prof. dr hab. Andrzej Pilc". pan.pl. 2025. Retrieved 14 July 2025.
  2. ^ "Prof. dr hab. Andrzej Pilc". Ludzie nauki. 2025. Retrieved 6 April 2025.
  3. ^ "Prof. dr hab. Andrzej Pilc". Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk. 2025. Retrieved 6 April 2025.
  4. ^ "Prof. dr hab. Andrzej Pilc". Google Scholar. 2025. Retrieved 6 April 2025.
  5. ^ a b Pilc, A. & Lloyd, K. G. (1984). Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sci 35. p. 2149-2154.{{cite book}}: CS1 maint: multiple names: authors list (link)
  6. ^ Tatarczynska, E. (2001). Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br.J Pharmacol 132. p. 1423-1430.
  7. ^ Palucha, A. & Pilc, A (2007). Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol.Ther. 115. p. 116-147.{{cite book}}: CS1 maint: multiple names: authors list (link)
  8. ^ Pilc, A., Wieronska, J. M. & Skolnick, P (2013). Glutamate-Based Antidepressants: Preclinical Psychopharmacology. Biological psychiatry 73. p. 1125-1132.{{cite book}}: CS1 maint: multiple names: authors list (link)
  9. ^ Jaworski, Piotr (2017). Niezwykła kariera Konstantego Walczaka. Kronika Miasta Łodzi 77.
  10. ^ "Prof. dr hab. Andrzej Pilc". radon.nauka.gov.pl. 2025. Retrieved 14 July 2025.
  11. ^ "Prof. dr hab. Andrzej Pilc". Portal Zarządzania Wiedzą UJ CM. 2025. Retrieved 14 July 2025.
  12. ^ Maslinski, C., Bielkiewicz, B., Nowak, J. Z. & Pilc, A (1975). Histamine content and synthesis in central and pheripheral nerve structures during stress. Agents Actions 5. p. 4-8.{{cite book}}: CS1 maint: multiple names: authors list (link)
  13. ^ Nowak, J. Z., Pilc, A., Lebrecht, U. & Maśliński, C (1977). Does histamine interact with cholinergic neurones in its cataleptogenic action in the rat?. Neuropharmacology 16. p. 841-847.{{cite book}}: CS1 maint: multiple names: authors list (link)
  14. ^ Pilc, A. & Vetulani, J (1982). Depression by chronic electroconvulsive treatment of clonidine hypotherma and clonidine binding to rat cortical membranes. Eur.J.Pharmacol 80. p. 109-113.{{cite book}}: CS1 maint: multiple names: authors list (link)
  15. ^ Pilc, A. & Vetulani, J (1982). Attenuation by chronic imipramine treatment ofclonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy. Brain Res. 238. p. 499-504.{{cite book}}: CS1 maint: multiple names: authors list (link)
  16. ^ Vetulani, J., Antkiewicz Michaluk, L., Rokosz Pelc, A. & Pilc, A (1983). Chronic electroconvulsive treatment enhances the density ofprazosin binding sites in the central nervous system of the rat. Brain Res. 275. p. 392-395.{{cite book}}: CS1 maint: multiple names: authors list (link)
  17. ^ Lloyd, K. G., Thuret, F. & Pilc, A. (1985). Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J.Pharmacol Exp.Ther. 235. p. 191-199.{{cite book}}: CS1 maint: multiple names: authors list (link)
  18. ^ Pilc, A. & Enna, S. J. (1986). Activation of alpha-2 adrenergic receptors augments neurotransmitter-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices. J.Pharmacol Exp.Ther. 237. p. 725-730.{{cite book}}: CS1 maint: multiple names: authors list (link)
  19. ^ Pilc, A. & Enna, S. J. (1985). Synergistic interaction between alpha- and beta-adrenergic receptors in rat brain slices: possible site for antidepressant drug action. Life Sci. 37. p. 1183-1194.{{cite book}}: CS1 maint: multiple names: authors list (link)
  20. ^ Pilc, A., Legutko, B., Frankiewicz, T. & Czyrak, A. (1994). Trans-(+-)-1-amino-1,3-cyclopentanedicarboxylate (trans-ACPD) stimulates cAMP accumulation in rat cerebral cortical slices but not in glial or neuronal cultures. Neurosci Lett. 169. p. 171-174.{{cite book}}: CS1 maint: multiple names: authors list (link)
  21. ^ Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A. (1999). Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 38. p. 1831-1839.{{cite book}}: CS1 maint: multiple names: authors list (link)
  22. ^ Konieczny, J., Ossowska, K., Wolfarth, S. & Pilc, A. (1998). LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. Naunyn-Schmied.Arch.Pharmacol. 358. p. 500-502.{{cite book}}: CS1 maint: multiple names: authors list (link)
  23. ^ Podkowa K, Podkowa A, Sałat K, Lenda T, Pilc A, Pałucha-Poniewiera A. (2016). Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495. Neuropharmacology 111. p. 169-179.{{cite book}}: CS1 maint: multiple names: authors list (link)
  24. ^ Podkowa, K., Pochwat, B., Branski, P., Pilc, A. & Palucha-Poniewiera, A. (2016). Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats. Psychopharmacology (Berl) 233. p. 2901-2914.{{cite book}}: CS1 maint: multiple names: authors list (link)
  25. ^ Chruścicka-Smaga, B., Machaczka, A., Szewczyk, B. & Pilc, A. (2023). Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies. Pharmacological Reports 6. p. 1341-1349.{{cite book}}: CS1 maint: multiple names: authors list (link)
  26. ^ Ioannidis, J. P. A., Boyack, K. W. & Baas, J. (2020). Updated science-wide author databases of standardized citation indicators. PLOS Biology 18. p. e3000918.{{cite book}}: CS1 maint: multiple names: authors list (link)
  27. ^ Pilc, A. (2023). Polscy farmakolodzy i farmaceuci na liście TOP 2%. Forum Akademickie 11. p. 16-17.
  28. ^ Pilc, A. (2002). Najczęściej cytowani naukowcy oraz prace naukowe w Polsce. Raport za lata 1965–2001 na podstawie bazy "Science Citation Inex" dotyczącej wszystkich światowych publikacji. Zagadnienia Naukoznawstwa 151. p. 65-82.
  29. ^ "The Tadeusz Browicz Award". Portal Zarządzania Wiedzą UJ CM. 2025. Retrieved 14 July 2025.
  30. ^ "The Jedrzej Śniadecki Award". Portal Zarządzania Wiedzą UJ CM. 2025. Retrieved 14 July 2025.
  31. ^ "The Jedrzej Śniadecki Medal". Portal Zarządzania Wiedzą UJ CM. 2025. Retrieved 14 July 2025.
  32. ^ "POSTANOWIENIE o nadaniu orderu i odznaczeń". prawo.pl. 2025. Retrieved 9 April 2025.
  33. ^ "Najlepszy naukowiec z Polski wg rankingu Top Medicine Scientists". Portal Zarządzania Wiedzą UJ CM. 2025. Retrieved 14 July 2025.
  34. ^ "Asia, India, Garhwal, Changabang and Dunagiri Attempts". publications.americanalpineclub.org. 2025. Retrieved 9 April 2025.
  35. ^ "Andrzej Pilc". przekroj.pl. 2025. Retrieved 9 April 2025.
  36. ^ "Królowie nauki". wprost.pl. 2025. Retrieved 9 April 2025.
  37. ^ "Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist". Scopus. Retrieved 7 April 2025.
  38. ^ "Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study". Scopus. Retrieved 7 April 2025.
  39. ^ "Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs". Scopus. Retrieved 7 April 2025.
  40. ^ "Upregulation of γ-aminobutyric acid (GABA) B binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressants and electroshock". Scopus. Retrieved 7 April 2025.
  41. ^ "Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats". Scopus. Retrieved 7 April 2025.
  42. ^ "Mood disorders: Regulation by metabotropic glutamate receptors". Scopus. Retrieved 7 April 2025.
  43. ^ "Activation of the mGlu7 receptor elicits antidepressant-like effects in mice". Scopus. Retrieved 7 April 2025.
  44. ^ "Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats". Scopus. Retrieved 7 April 2025.
  45. ^ "Glutamate-based antidepressants: Preclinical psychopharmacology". Scopus. Retrieved 7 April 2025.
  46. ^ "Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment". Scopus. Retrieved 7 April 2025.



This page will be placed in the following categories if it is moved to the article namespace.
Categories:

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Andrzej_Mikołaj_Pilc&oldid=1304494539"